BackNanoVibronix Overview

NanoVibronix Goodwill

Track NanoVibronix's goodwill ($29M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$29.08M
↓ 14.24% YoYΔ $-4.83M vs prior year quarter

Peer average

Loading

NanoVibronix Goodwill History

Loading

NanoVibronix vs. peers: Goodwill Comparison

Loading

NanoVibronix Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NanoVibronix (NAOV) FAQ

As of the most recent data (March 2026), NAOV shows a goodwill of $29M. That compares with $34M in the prior-year period — down 14.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAOV's goodwill is now $29M (was $34M) — a 14.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NanoVibronix is outperforming or lagging.

Tracking NAOV's goodwill over time shows whether NanoVibronix is scaling, shrinking, or reshaping that part of the business. The current reading is $29M That compares with $34M in the prior-year period — down 14.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has NanoVibronix's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $29M) with ownership activity and broader fundamentals.

NanoVibronix's goodwill is $29M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.